27-Feb-2026
Alcon (ALC) Receives a Hold from Barclays
TipRanks (Fri, 27-Feb 2:25 AM ET)
This US Bancorp Analyst Turns Bullish; Here Are Top 4 Upgrades For Thursday
Benzinga (Thu, 26-Feb 1:37 PM ET)
TipRanks (Thu, 26-Feb 8:30 AM ET)
Analysts Conflicted on These Healthcare Names: Teladoc (TDOC) and Alcon (ALC)
TipRanks (Thu, 26-Feb 5:50 AM ET)
Alcon targets 5%–7% sales growth in 2026 while expanding Unity platform and launching new IOLs
Seeking Alpha News (Wed, 25-Feb 1:38 PM ET)
Alcon (ALC) Receives a Sell from Bank of America Securities
TipRanks (Wed, 25-Feb 7:38 AM ET)
Market Chameleon (Wed, 25-Feb 2:08 AM ET)
Alcon (ALC): Solid Fundamentals and Market Recovery Support Buy Rating
TipRanks (Wed, 25-Feb 1:45 AM ET)
Alcon’s 2025 Annual Report Showcases Innovation-Led Growth and Strategic Eye-Care Expansion
TipRanks (Tue, 24-Feb 6:06 PM ET)
Alcon slips as Q4 financial results miss on both lines
Seeking Alpha News (Tue, 24-Feb 5:45 PM ET)
Alcon is one of the leading visioncare companies in the world. Following nine years as a Novartis subsidiary, it was spun off as a public company in April 2019. Alcon operates in two segments: visioncare and surgical. Visioncare comprises contact lenses, lenscare solutions, and a suite of ocular health products. With brands like Dailies, Total1, and Air Optix, Alcon controls about one fourth of the US contact lens market. Surgical comprises intraocular lenses, ophthalmic surgical equipment, and consumables used during surgeries. Its main products include Centurion, a phacoemulsification device used during cataract surgeries, and a portfolio of IOLs including PanOptix and Vivity. Alcon has one of the largest installed bases of eye surgical equipment in the world.
Alcon trades on the NYSE stock market under the symbol ALC.
As of February 27, 2026, ALC stock price climbed to $87.18 with 1,100,427 million shares trading.
ALC has a beta of 0.82, meaning it tends to be less sensitive to market movements. ALC has a correlation of 0.26 to the broad based SPY ETF.
ALC has a market cap of $43.12 billion. This is considered a Large Cap stock.
Last quarter Alcon reported $3 billion in Revenue and $.78 earnings per share. This fell short of revenue expectation by $-7 million and missed earnings estimates by -$.06.
In the last 3 years, ALC traded as high as $101.10 and as low as $63.78.
The top ETF exchange traded funds that ALC belongs to (by Net Assets): EQTY, DFIV, DFAI, DFIC, DFAX.
ALC has underperformed the market in the last year with a return of -4.9%, while SPY returned +18.5%. This shows that you would have done better investing in the overall market (through SPY) over the last year than in ALC shares. However, ALC has outperformed the market in the last 3 month and 2 week periods, returning +10.1% and +10.1%, while SPY returned +1.2% and +0.6%, respectively. This indicates ALC has been having a stronger performance recently.
ALC support price is $85.29 and resistance is $88.15 (based on 1 day standard deviation move). This means that using the most recent 20 day stock volatility and applying a one standard deviation move around the stock's closing price, stastically there is a 67% probability that ALC shares will trade within this expected range on the day.